IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 66 filers reported holding IMMUNIC INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,119,680 | -43.7% | 761,687 | -3.8% | 0.03% | -55.6% |
Q2 2023 | $1,987,134 | +94.4% | 791,687 | +15.4% | 0.06% | +103.2% |
Q1 2023 | $1,022,337 | -99.8% | 686,132 | +246.6% | 0.03% | +158.3% |
Q3 2022 | $626,000,000 | -22.4% | 197,988 | -14.9% | 0.01% | 0.0% |
Q2 2022 | $807,000,000 | – | 232,591 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 1,788,160 | $2,628,595 | 2.41% |
Gratus Capital, LLC | 1,686,455 | $2,479,089 | 0.17% |
INNOVIS ASSET MANAGEMENT LLC | 272,457 | $400,512 | 0.15% |
Parkman Healthcare Partners LLC | 562,506 | $826,884 | 0.15% |
RTW INVESTMENTS, LP | 4,335,255 | $6,372,825 | 0.13% |
Logos Global Management LP | 421,184 | $619,140 | 0.08% |
Ikarian Capital, LLC | 450,000 | $661,501 | 0.08% |
BVF INC/IL | 1,149,425 | $1,689,655 | 0.05% |
Soleus Capital Management, L.P. | 300,000 | $441,000 | 0.04% |
COWEN AND COMPANY, LLC | 317,059 | $466,076 | 0.03% |